![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication May 30, 2006.
Revised August 14, 2006.
Accepted for publication August 15, 2006.
The aim of this study was to identify cell adhesion
molecules that could serve as targets of the human
follicle associated epithelium (FAE) overlying Peyer's
patches and to assess nanoparticle uptake levels across
this epithelium. We first studied the expression of the
mouse M-cell marker
1-integrin and used a model of
human FAE derived from intestinal epithelial Caco-2 cells
and Raji B-cells to identify additional potential targets
by cDNA-array. The protein expression of the potential
targets in the model FAE and in human ileal FAE tissues
was quantified by immunofluorescence. Integrin targeting
was studied by investigating the transport of RGD-coated
(integrin-binding), RGE-coated (non-integrin-binding) and
uncoated nanoparticles across human ileal FAE and Villus
Epithelial (VE) specimens mounted in Ussing chambers.
Both
1-integrin and the cell adhesion molecule CD9
were more abundantly expressed in the model and human
ileal FAE compared with the Caco-2 control cells or VE.
Uncoated nanoparticles were not taken up across either
FAE or VE, while general integrin targeting with RGD
improved the nanoparticle transport dramatically across
the FAE. Compared with RGE, RGD improved transport four-
fold across the FAE. RGD also improved nanoparticle
transport across the VE, but to the same low extent as
RGE. In conclusion,
1-integrin and CD9 were
identified as targets in human FAE. The difference in RGD-
and RGE-mediated transport across the FAE, but not the
VE, suggest that a specific integrin interaction was the
dominating mechanism for improved nanoparticle uptake
across the FAE, while charge interaction contributed
substantially to the improved VE uptake.
Key words:
epithel, integrins, intestine, microarray, targeting, transport